APO Research

APO RESEARCH · REPORT

In Vitro Cytotoxicity Testing Service

Selected research

Market Structure

Global In Vitro Cytotoxicity Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global In Vitro Cytotoxicity Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for In Vitro Cytotoxicity Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of In Vitro Cytotoxicity Testing Service include Eurofins, SGS, Sartorius, UL, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global In Vitro Cytotoxicity Testing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In Vitro Cytotoxicity Testing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In Vitro Cytotoxicity Testing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In Vitro Cytotoxicity Testing Service market size, projected growth trends, production technologies, key applications, and end-use industries.

In Vitro Cytotoxicity Testing Service Segment by Company

Eurofins

SGS

Sartorius

UL

Emery Pharma

Nelson Labs

UFAG Laboratorien AG

Pacific BioLabs

NorthEast BioLab

Biosafe Ltd

Creative Bioarray

Evercyte

IONTOX

Applied StemCell

Xenometrix AG

TÜV SÜD

Medicilon

Huatongwei

In Vitro Cytotoxicity Testing Service Segment by Type

MTT Assay Method

LDH Assay Method

Neutral Red Uptake Assay Method

Others

In Vitro Cytotoxicity Testing Service Segment by Application

Drug

Medical Instruments

Cosmetics and Personal Care

Others

In Vitro Cytotoxicity Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Cytotoxicity Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vitro Cytotoxicity Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Cytotoxicity Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In Vitro Cytotoxicity Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vitro Cytotoxicity Testing Service industry.

Chapter 3: Detailed analysis of In Vitro Cytotoxicity Testing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Cytotoxicity Testing Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of MTT Assay Method Table 3. Key Players of LDH Assay Method Table 4. Key Players of Neutral Red Uptake Assay Method Table 3. Key Players of Others Table 4. Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Drug Table 6. Key Players of Medical Instruments Table 7. Key Players of Cosmetics and Personal Care Table 8. Key Players of Others Table 9. Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global In Vitro Cytotoxicity Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global In Vitro Cytotoxicity Testing Service Market Share by Region (2021-2026) Table 12. Global In Vitro Cytotoxicity Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global In Vitro Cytotoxicity Testing Service Market Share by Region (2027-2032) Table 14. In Vitro Cytotoxicity Testing Service Industry Trends Table 15. In Vitro Cytotoxicity Testing Service Industry Drivers Table 16. In Vitro Cytotoxicity Testing Service Industry Opportunities and Challenges Table 17. In Vitro Cytotoxicity Testing Service Industry Restraints Table 18. Global In Vitro Cytotoxicity Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Company (2021-2026) Table 20. Global In Vitro Cytotoxicity Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global In Vitro Cytotoxicity Testing Service Key Company Head Office and Area Served Table 22. Global In Vitro Cytotoxicity Testing Service Company, Product Type & Application Table 23. Global In Vitro Cytotoxicity Testing Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global In Vitro Cytotoxicity Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global In Vitro Cytotoxicity Testing Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Type (2021-2026) Table 30. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Type (2027-2032) Table 31. Global In Vitro Cytotoxicity Testing Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Application (2021-2026) Table 35. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Application (2027-2032) Table 36. Eurofins Company Information Table 37. Eurofins Business Overview Table 38. Eurofins In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins In Vitro Cytotoxicity Testing Service Product Portfolio Table 40. Eurofins Recent Development Table 41. SGS Company Information Table 42. SGS Business Overview Table 43. SGS In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. SGS In Vitro Cytotoxicity Testing Service Product Portfolio Table 45. SGS Recent Development Table 46. Sartorius Company Information Table 47. Sartorius Business Overview Table 48. Sartorius In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Sartorius In Vitro Cytotoxicity Testing Service Product Portfolio Table 50. Sartorius Recent Development Table 51. UL Company Information Table 52. UL Business Overview Table 53. UL In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. UL In Vitro Cytotoxicity Testing Service Product Portfolio Table 55. UL Recent Development Table 56. Emery Pharma Company Information Table 57. Emery Pharma Business Overview Table 58. Emery Pharma In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Emery Pharma In Vitro Cytotoxicity Testing Service Product Portfolio Table 60. Emery Pharma Recent Development Table 61. Nelson Labs Company Information Table 62. Nelson Labs Business Overview Table 63. Nelson Labs In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Nelson Labs In Vitro Cytotoxicity Testing Service Product Portfolio Table 65. Nelson Labs Recent Development Table 66. UFAG Laboratorien AG Company Information Table 67. UFAG Laboratorien AG Business Overview Table 68. UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Product Portfolio Table 70. UFAG Laboratorien AG Recent Development Table 71. Pacific BioLabs Company Information Table 72. Pacific BioLabs Business Overview Table 73. Pacific BioLabs In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Pacific BioLabs In Vitro Cytotoxicity Testing Service Product Portfolio Table 75. Pacific BioLabs Recent Development Table 76. NorthEast BioLab Company Information Table 77. NorthEast BioLab Business Overview Table 78. NorthEast BioLab In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. NorthEast BioLab In Vitro Cytotoxicity Testing Service Product Portfolio Table 80. NorthEast BioLab Recent Development Table 81. Biosafe Ltd Company Information Table 82. Biosafe Ltd Business Overview Table 83. Biosafe Ltd In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Biosafe Ltd In Vitro Cytotoxicity Testing Service Product Portfolio Table 85. Biosafe Ltd Recent Development Table 86. Creative Bioarray Company Information Table 87. Creative Bioarray Business Overview Table 88. Creative Bioarray In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Creative Bioarray In Vitro Cytotoxicity Testing Service Product Portfolio Table 90. Creative Bioarray Recent Development Table 91. Evercyte Company Information Table 92. Evercyte Business Overview Table 93. Evercyte In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Evercyte In Vitro Cytotoxicity Testing Service Product Portfolio Table 95. Evercyte Recent Development Table 96. IONTOX Company Information Table 97. IONTOX Business Overview Table 98. IONTOX In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. IONTOX In Vitro Cytotoxicity Testing Service Product Portfolio Table 100. IONTOX Recent Development Table 101. Applied StemCell Company Information Table 102. Applied StemCell Business Overview Table 103. Applied StemCell In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Applied StemCell In Vitro Cytotoxicity Testing Service Product Portfolio Table 105. Applied StemCell Recent Development Table 106. Xenometrix AG Company Information Table 107. Xenometrix AG Business Overview Table 108. Xenometrix AG In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Xenometrix AG In Vitro Cytotoxicity Testing Service Product Portfolio Table 110. Xenometrix AG Recent Development Table 111. TÜV SÜD Company Information Table 112. TÜV SÜD Business Overview Table 113. TÜV SÜD In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. TÜV SÜD In Vitro Cytotoxicity Testing Service Product Portfolio Table 115. TÜV SÜD Recent Development Table 116. Medicilon Company Information Table 117. Medicilon Business Overview Table 118. Medicilon In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Medicilon In Vitro Cytotoxicity Testing Service Product Portfolio Table 120. Medicilon Recent Development Table 121. Huatongwei Company Information Table 122. Huatongwei Business Overview Table 123. Huatongwei In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Huatongwei In Vitro Cytotoxicity Testing Service Product Portfolio Table 125. Huatongwei Recent Development Table 126. North America In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 127. North America In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 128. North America In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 129. North America In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 130. North America In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026) Table 132. North America In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032) Table 133. Europe In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 134. Europe In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 135. Europe In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 136. Europe In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 137. Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026) Table 139. Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032) Table 140. China In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 141. China In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 142. China In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 143. China In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 145. Asia In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 146. Asia In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 147. Asia In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026) Table 150. Asia In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032) Table 151. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026) Table 157. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. In Vitro Cytotoxicity Testing Service Product Image Figure 2. Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global In Vitro Cytotoxicity Testing Service Market Share by Type: 2025 VS 2032 Figure 4. MTT Assay Method Image Figure 5. LDH Assay Method Image Figure 6. Neutral Red Uptake Assay Method Image Figure 7. Others Image Figure 8. Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global In Vitro Cytotoxicity Testing Service Market Share by Application: 2025 VS 2032 Figure 10. Drug Image Figure 11. Medical Instruments Image Figure 12. Cosmetics and Personal Care Image Figure 13. Others Image Figure 14. Global In Vitro Cytotoxicity Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 16. Global In Vitro Cytotoxicity Testing Service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global In Vitro Cytotoxicity Testing Service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 In Vitro Cytotoxicity Testing Service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global In Vitro Cytotoxicity Testing Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Type (2021-2032) Figure 23. Global In Vitro Cytotoxicity Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global In Vitro Cytotoxicity Testing Service Revenue Market Share by Application (2021-2032) Figure 25. North America In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 26. North America In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032) Figure 27. North America In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032) Figure 28. North America In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032) Figure 29. United States In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 30. Canada In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032) Figure 34. Europe In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032) Figure 35. Europe In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032) Figure 36. Germany In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 37. France In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 39. Italy In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 40. Russia In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 42. China In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 43. China In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032) Figure 44. China In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032) Figure 45. Asia In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 46. Asia In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032) Figure 47. Asia In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032) Figure 48. Asia In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032) Figure 49. Japan In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 53. India In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 54. Australia In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032) Figure 59. Brazil In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 64. UAE In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 66. Chile In Vitro Cytotoxicity Testing Service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • MTT Assay Method
  • LDH Assay Method
  • Neutral Red Uptake Assay Method
  • Others
Applications
  • Drug
  • Medical Instruments
  • Cosmetics and Personal Care
  • Others
Companies covered
  • Eurofins
  • SGS
  • Sartorius
  • UL
  • Emery Pharma
  • Nelson Labs
  • UFAG Laboratorien AG
  • Pacific BioLabs
  • NorthEast BioLab
  • Biosafe Ltd
  • Creative Bioarray
  • Evercyte
  • IONTOX
  • Applied StemCell
  • Xenometrix AG
  • TÜV SÜD
  • Medicilon
  • Huatongwei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 MTT Assay Method
  5. 1.2.3 LDH Assay Method
  6. 1.2.4 Neutral Red Uptake Assay Method
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global In Vitro Cytotoxicity Testing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Drug
  11. 1.3.3 Medical Instruments
  12. 1.3.4 Cosmetics and Personal Care
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global In Vitro Cytotoxicity Testing Service Growth Trends by Region
  16. 1.5.1 Global In Vitro Cytotoxicity Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 In Vitro Cytotoxicity Testing Service Market Size by Region (2021-2026)
  18. 1.5.3 In Vitro Cytotoxicity Testing Service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global In Vitro Cytotoxicity Testing Service Market Dynamics
  1. 2.1 In Vitro Cytotoxicity Testing Service Industry Trends
  2. 2.2 In Vitro Cytotoxicity Testing Service Industry Drivers
  3. 2.3 In Vitro Cytotoxicity Testing Service Industry Opportunities and Challenges
  4. 2.4 In Vitro Cytotoxicity Testing Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global In Vitro Cytotoxicity Testing Service Revenue by Company (2021-2026)
  2. 3.2 Global In Vitro Cytotoxicity Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global In Vitro Cytotoxicity Testing Service Key Company Head office and Area Served
  4. 3.4 Global In Vitro Cytotoxicity Testing Service Company, Product Type & Application
  5. 3.5 Global In Vitro Cytotoxicity Testing Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global In Vitro Cytotoxicity Testing Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 In Vitro Cytotoxicity Testing Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 In Vitro Cytotoxicity Testing Service Tier 1, Tier 2, and Tier 3
4 In Vitro Cytotoxicity Testing Service Market by Type
  1. 4.1 Global In Vitro Cytotoxicity Testing Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2032)
  3. 4.3 Global In Vitro Cytotoxicity Testing Service Market Size Share by Type (2021-2032)
5 In Vitro Cytotoxicity Testing Service Market by Application
  1. 5.1 Global In Vitro Cytotoxicity Testing Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2032)
  3. 5.3 Global In Vitro Cytotoxicity Testing Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins
  2. 6.1.1 Eurofins Company Information
  3. 6.1.2 Eurofins Business Overview
  4. 6.1.3 Eurofins In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins In Vitro Cytotoxicity Testing Service Product Portfolio
  6. 6.1.5 Eurofins Recent Developments
  7. 6.2 SGS
  8. 6.2.1 SGS Company Information
  9. 6.2.2 SGS Business Overview
  10. 6.2.3 SGS In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 SGS In Vitro Cytotoxicity Testing Service Product Portfolio
  12. 6.2.5 SGS Recent Developments
  13. 6.3 Sartorius
  14. 6.3.1 Sartorius Company Information
  15. 6.3.2 Sartorius Business Overview
  16. 6.3.3 Sartorius In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sartorius In Vitro Cytotoxicity Testing Service Product Portfolio
  18. 6.3.5 Sartorius Recent Developments
  19. 6.4 UL
  20. 6.4.1 UL Company Information
  21. 6.4.2 UL Business Overview
  22. 6.4.3 UL In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 UL In Vitro Cytotoxicity Testing Service Product Portfolio
  24. 6.4.5 UL Recent Developments
  25. 6.5 Emery Pharma
  26. 6.5.1 Emery Pharma Company Information
  27. 6.5.2 Emery Pharma Business Overview
  28. 6.5.3 Emery Pharma In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Emery Pharma In Vitro Cytotoxicity Testing Service Product Portfolio
  30. 6.5.5 Emery Pharma Recent Developments
  31. 6.6 Nelson Labs
  32. 6.6.1 Nelson Labs Company Information
  33. 6.6.2 Nelson Labs Business Overview
  34. 6.6.3 Nelson Labs In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Nelson Labs In Vitro Cytotoxicity Testing Service Product Portfolio
  36. 6.6.5 Nelson Labs Recent Developments
  37. 6.7 UFAG Laboratorien AG
  38. 6.7.1 UFAG Laboratorien AG Company Information
  39. 6.7.2 UFAG Laboratorien AG Business Overview
  40. 6.7.3 UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Product Portfolio
  42. 6.7.5 UFAG Laboratorien AG Recent Developments
  43. 6.8 Pacific BioLabs
  44. 6.8.1 Pacific BioLabs Company Information
  45. 6.8.2 Pacific BioLabs Business Overview
  46. 6.8.3 Pacific BioLabs In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pacific BioLabs In Vitro Cytotoxicity Testing Service Product Portfolio
  48. 6.8.5 Pacific BioLabs Recent Developments
  49. 6.9 NorthEast BioLab
  50. 6.9.1 NorthEast BioLab Company Information
  51. 6.9.2 NorthEast BioLab Business Overview
  52. 6.9.3 NorthEast BioLab In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 NorthEast BioLab In Vitro Cytotoxicity Testing Service Product Portfolio
  54. 6.9.5 NorthEast BioLab Recent Developments
  55. 6.10 Biosafe Ltd
  56. 6.10.1 Biosafe Ltd Company Information
  57. 6.10.2 Biosafe Ltd Business Overview
  58. 6.10.3 Biosafe Ltd In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Biosafe Ltd In Vitro Cytotoxicity Testing Service Product Portfolio
  60. 6.10.5 Biosafe Ltd Recent Developments
  61. 6.11 Creative Bioarray
  62. 6.11.1 Creative Bioarray Company Information
  63. 6.11.2 Creative Bioarray Business Overview
  64. 6.11.3 Creative Bioarray In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Creative Bioarray In Vitro Cytotoxicity Testing Service Product Portfolio
  66. 6.11.5 Creative Bioarray Recent Developments
  67. 6.12 Evercyte
  68. 6.12.1 Evercyte Company Information
  69. 6.12.2 Evercyte Business Overview
  70. 6.12.3 Evercyte In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Evercyte In Vitro Cytotoxicity Testing Service Product Portfolio
  72. 6.12.5 Evercyte Recent Developments
  73. 6.13 IONTOX
  74. 6.13.1 IONTOX Company Information
  75. 6.13.2 IONTOX Business Overview
  76. 6.13.3 IONTOX In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 IONTOX In Vitro Cytotoxicity Testing Service Product Portfolio
  78. 6.13.5 IONTOX Recent Developments
  79. 6.14 Applied StemCell
  80. 6.14.1 Applied StemCell Company Information
  81. 6.14.2 Applied StemCell Business Overview
  82. 6.14.3 Applied StemCell In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Applied StemCell In Vitro Cytotoxicity Testing Service Product Portfolio
  84. 6.14.5 Applied StemCell Recent Developments
  85. 6.15 Xenometrix AG
  86. 6.15.1 Xenometrix AG Company Information
  87. 6.15.2 Xenometrix AG Business Overview
  88. 6.15.3 Xenometrix AG In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Xenometrix AG In Vitro Cytotoxicity Testing Service Product Portfolio
  90. 6.15.5 Xenometrix AG Recent Developments
  91. 6.16 TÜV SÜD
  92. 6.16.1 TÜV SÜD Company Information
  93. 6.16.2 TÜV SÜD Business Overview
  94. 6.16.3 TÜV SÜD In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 TÜV SÜD In Vitro Cytotoxicity Testing Service Product Portfolio
  96. 6.16.5 TÜV SÜD Recent Developments
  97. 6.17 Medicilon
  98. 6.17.1 Medicilon Company Information
  99. 6.17.2 Medicilon Business Overview
  100. 6.17.3 Medicilon In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Medicilon In Vitro Cytotoxicity Testing Service Product Portfolio
  102. 6.17.5 Medicilon Recent Developments
  103. 6.18 Huatongwei
  104. 6.18.1 Huatongwei Company Information
  105. 6.18.2 Huatongwei Business Overview
  106. 6.18.3 Huatongwei In Vitro Cytotoxicity Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Huatongwei In Vitro Cytotoxicity Testing Service Product Portfolio
  108. 6.18.5 Huatongwei Recent Developments
7 North America
  1. 7.1 North America In Vitro Cytotoxicity Testing Service Market Size (2021-2032)
  2. 7.2 North America In Vitro Cytotoxicity Testing Service Market Size by Type
  3. 7.2.1 North America In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026)
  4. 7.2.2 North America In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032)
  5. 7.2.3 North America In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032)
  6. 7.3 North America In Vitro Cytotoxicity Testing Service Market Size by Application
  7. 7.3.1 North America In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026)
  8. 7.3.2 North America In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032)
  9. 7.3.3 North America In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032)
  10. 7.4 North America In Vitro Cytotoxicity Testing Service Market Size by Country
  11. 7.4.1 North America In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
  13. 7.4.3 North America In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032)
  14. 7.4.4 North America In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe In Vitro Cytotoxicity Testing Service Market Size (2021-2032)
  2. 8.2 Europe In Vitro Cytotoxicity Testing Service Market Size by Type
  3. 8.2.1 Europe In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032)
  6. 8.3 Europe In Vitro Cytotoxicity Testing Service Market Size by Application
  7. 8.3.1 Europe In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032)
  10. 8.4 Europe In Vitro Cytotoxicity Testing Service Market Size by Country
  11. 8.4.1 Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China In Vitro Cytotoxicity Testing Service Market Size (2021-2032)
  2. 9.2 China In Vitro Cytotoxicity Testing Service Market Size by Type
  3. 9.2.1 China In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026)
  4. 9.2.2 China In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032)
  5. 9.2.3 China In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032)
  6. 9.3 China In Vitro Cytotoxicity Testing Service Market Size by Application
  7. 9.3.1 China In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026)
  8. 9.3.2 China In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032)
  9. 9.3.3 China In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia In Vitro Cytotoxicity Testing Service Market Size (2021-2032)
  2. 10.2 Asia In Vitro Cytotoxicity Testing Service Market Size by Type
  3. 10.2.1 Asia In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032)
  6. 10.3 Asia In Vitro Cytotoxicity Testing Service Market Size by Application
  7. 10.3.1 Asia In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032)
  10. 10.4 Asia In Vitro Cytotoxicity Testing Service Market Size by Country
  11. 10.4.1 Asia In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa In Vitro Cytotoxicity Testing Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research